 | • レポートコード：MRC2-11QY03899 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はナノメディシンのグローバル市場について調査・分析したレポートです。種類別（量子ドット、ナノ粒子、ナノシェル、ナノチューブ、ナノデバイス）市場規模、用途別（腫瘍、感染症、心臓病学、整形外科、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ナノメディシンの競争状況、市場シェア ・世界のナノメディシン市場：種類別市場規模 2015年-2020年（量子ドット、ナノ粒子、ナノシェル、ナノチューブ、ナノデバイス） ・世界のナノメディシン市場：種類別市場規模予測 2021年-2026年（量子ドット、ナノ粒子、ナノシェル、ナノチューブ、ナノデバイス） ・世界のナノメディシン市場：用途別市場規模 2015年-2020年（腫瘍、感染症、心臓病学、整形外科、その他） ・世界のナノメディシン市場：用途別市場規模予測 2021年-2026年（腫瘍、感染症、心臓病学、整形外科、その他） ・北米のナノメディシン市場分析：米国、カナダ ・ヨーロッパのナノメディシン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのナノメディシン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のナノメディシン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのナノメディシン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Combimatrix、Ablynx、Abraxis Bioscience、Celgene、Mallinckrodt、Arrowhead Research、GE Healthcare、Merck、Pfizer、Nanosphere、Epeius Biotechnologies、Cytimmune Sciences、Nanospectra Biosciences ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.
As per the WHO factsheet, cancer is found to be one of the major causes of mortality and morbidity worldwide, with approximately 14 million new cases in 2012 and 8.2 million cancer-related deaths. Thus, demand for nanomedicine in order to curb such high incidence rate is expected to boost market progress during the forecast period.
Market Analysis and Insights: Global Nanomedicine Market
The global Nanomedicine market size is projected to reach US$ 160.3 million by 2026, from US$ 150 million in 2020, at a CAGR of 6.4%% during 2021-2026.
Global Nanomedicine Scope and Market Size
Nanomedicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nanomedicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Combimatrix
Ablynx
Abraxis Bioscience
Celgene
Mallinckrodt
Arrowhead Research
GE Healthcare
Merck
Pfizer
Nanosphere
Epeius Biotechnologies
Cytimmune Sciences
Nanospectra Biosciences
Market segment by Type, the product can be split into
Quantum dots
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Market segment by Application, split into
oncology
Infectious diseases
Cardiology
Orthopedics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nanomedicine Revenue
1.4 Market by Type
1.4.1 Global Nanomedicine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Quantum dots
1.4.3 Nanoparticles
1.4.4 Nanoshells
1.4.5 Nanotubes
1.4.6 Nanodevices
1.5 Market by Application
1.5.1 Global Nanomedicine Market Share by Application: 2020 VS 2026
1.5.2 oncology
1.5.3 Infectious diseases
1.5.4 Cardiology
1.5.5 Orthopedics
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Nanomedicine Market Perspective (2015-2026)
2.2 Global Nanomedicine Growth Trends by Regions
2.2.1 Nanomedicine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Nanomedicine Historic Market Share by Regions (2015-2020)
2.2.3 Nanomedicine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Nanomedicine Market Growth Strategy
2.3.6 Primary Interviews with Key Nanomedicine Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Nanomedicine Players by Market Size
3.1.1 Global Top Nanomedicine Players by Revenue (2015-2020)
3.1.2 Global Nanomedicine Revenue Market Share by Players (2015-2020)
3.1.3 Global Nanomedicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Nanomedicine Market Concentration Ratio
3.2.1 Global Nanomedicine Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Nanomedicine Revenue in 2019
3.3 Nanomedicine Key Players Head office and Area Served
3.4 Key Players Nanomedicine Product Solution and Service
3.5 Date of Enter into Nanomedicine Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Nanomedicine Historic Market Size by Type (2015-2020)
4.2 Global Nanomedicine Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Nanomedicine Market Size by Application (2015-2020)
5.2 Global Nanomedicine Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Nanomedicine Market Size (2015-2020)
6.2 Nanomedicine Key Players in North America (2019-2020)
6.3 North America Nanomedicine Market Size by Type (2015-2020)
6.4 North America Nanomedicine Market Size by Application (2015-2020)
7 Europe
7.1 Europe Nanomedicine Market Size (2015-2020)
7.2 Nanomedicine Key Players in Europe (2019-2020)
7.3 Europe Nanomedicine Market Size by Type (2015-2020)
7.4 Europe Nanomedicine Market Size by Application (2015-2020)
8 China
8.1 China Nanomedicine Market Size (2015-2020)
8.2 Nanomedicine Key Players in China (2019-2020)
8.3 China Nanomedicine Market Size by Type (2015-2020)
8.4 China Nanomedicine Market Size by Application (2015-2020)
9 Japan
9.1 Japan Nanomedicine Market Size (2015-2020)
9.2 Nanomedicine Key Players in Japan (2019-2020)
9.3 Japan Nanomedicine Market Size by Type (2015-2020)
9.4 Japan Nanomedicine Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Nanomedicine Market Size (2015-2020)
10.2 Nanomedicine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Nanomedicine Market Size by Type (2015-2020)
10.4 Southeast Asia Nanomedicine Market Size by Application (2015-2020)
11 India
11.1 India Nanomedicine Market Size (2015-2020)
11.2 Nanomedicine Key Players in India (2019-2020)
11.3 India Nanomedicine Market Size by Type (2015-2020)
11.4 India Nanomedicine Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Nanomedicine Market Size (2015-2020)
12.2 Nanomedicine Key Players in Central & South America (2019-2020)
12.3 Central & South America Nanomedicine Market Size by Type (2015-2020)
12.4 Central & South America Nanomedicine Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Combimatrix
13.1.1 Combimatrix Company Details
13.1.2 Combimatrix Business Overview
13.1.3 Combimatrix Nanomedicine Introduction
13.1.4 Combimatrix Revenue in Nanomedicine Business (2015-2020))
13.1.5 Combimatrix Recent Development
13.2 Ablynx
13.2.1 Ablynx Company Details
13.2.2 Ablynx Business Overview
13.2.3 Ablynx Nanomedicine Introduction
13.2.4 Ablynx Revenue in Nanomedicine Business (2015-2020)
13.2.5 Ablynx Recent Development
13.3 Abraxis Bioscience
13.3.1 Abraxis Bioscience Company Details
13.3.2 Abraxis Bioscience Business Overview
13.3.3 Abraxis Bioscience Nanomedicine Introduction
13.3.4 Abraxis Bioscience Revenue in Nanomedicine Business (2015-2020)
13.3.5 Abraxis Bioscience Recent Development
13.4 Celgene
13.4.1 Celgene Company Details
13.4.2 Celgene Business Overview
13.4.3 Celgene Nanomedicine Introduction
13.4.4 Celgene Revenue in Nanomedicine Business (2015-2020)
13.4.5 Celgene Recent Development
13.5 Mallinckrodt
13.5.1 Mallinckrodt Company Details
13.5.2 Mallinckrodt Business Overview
13.5.3 Mallinckrodt Nanomedicine Introduction
13.5.4 Mallinckrodt Revenue in Nanomedicine Business (2015-2020)
13.5.5 Mallinckrodt Recent Development
13.6 Arrowhead Research
13.6.1 Arrowhead Research Company Details
13.6.2 Arrowhead Research Business Overview
13.6.3 Arrowhead Research Nanomedicine Introduction
13.6.4 Arrowhead Research Revenue in Nanomedicine Business (2015-2020)
13.6.5 Arrowhead Research Recent Development
13.7 GE Healthcare
13.7.1 GE Healthcare Company Details
13.7.2 GE Healthcare Business Overview
13.7.3 GE Healthcare Nanomedicine Introduction
13.7.4 GE Healthcare Revenue in Nanomedicine Business (2015-2020)
13.7.5 GE Healthcare Recent Development
13.8 Merck
13.8.1 Merck Company Details
13.8.2 Merck Business Overview
13.8.3 Merck Nanomedicine Introduction
13.8.4 Merck Revenue in Nanomedicine Business (2015-2020)
13.8.5 Merck Recent Development
13.9 Pfizer
13.9.1 Pfizer Company Details
13.9.2 Pfizer Business Overview
13.9.3 Pfizer Nanomedicine Introduction
13.9.4 Pfizer Revenue in Nanomedicine Business (2015-2020)
13.9.5 Pfizer Recent Development
13.10 Nanosphere
13.10.1 Nanosphere Company Details
13.10.2 Nanosphere Business Overview
13.10.3 Nanosphere Nanomedicine Introduction
13.10.4 Nanosphere Revenue in Nanomedicine Business (2015-2020)
13.10.5 Nanosphere Recent Development
13.11 Epeius Biotechnologies
10.11.1 Epeius Biotechnologies Company Details
10.11.2 Epeius Biotechnologies Business Overview
10.11.3 Epeius Biotechnologies Nanomedicine Introduction
10.11.4 Epeius Biotechnologies Revenue in Nanomedicine Business (2015-2020)
10.11.5 Epeius Biotechnologies Recent Development
13.12 Cytimmune Sciences
10.12.1 Cytimmune Sciences Company Details
10.12.2 Cytimmune Sciences Business Overview
10.12.3 Cytimmune Sciences Nanomedicine Introduction
10.12.4 Cytimmune Sciences Revenue in Nanomedicine Business (2015-2020)
10.12.5 Cytimmune Sciences Recent Development
13.13 Nanospectra Biosciences
10.13.1 Nanospectra Biosciences Company Details
10.13.2 Nanospectra Biosciences Business Overview
10.13.3 Nanospectra Biosciences Nanomedicine Introduction
10.13.4 Nanospectra Biosciences Revenue in Nanomedicine Business (2015-2020)
10.13.5 Nanospectra Biosciences Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Nanomedicine Key Market Segments
Table 2. Key Players Covered: Ranking by Nanomedicine Revenue
Table 3. Ranking of Global Top Nanomedicine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Nanomedicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Quantum dots
Table 6. Key Players of Nanoparticles
Table 7. Key Players of Nanoshells
Table 8. Key Players of Nanotubes
Table 9. Key Players of Nanodevices
Table 10. Global Nanomedicine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Nanomedicine Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Nanomedicine Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Nanomedicine Market Share by Regions (2015-2020)
Table 14. Global Nanomedicine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Nanomedicine Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Nanomedicine Market Growth Strategy
Table 20. Main Points Interviewed from Key Nanomedicine Players
Table 21. Global Nanomedicine Revenue by Players (2015-2020) (Million US$)
Table 22. Global Nanomedicine Market Share by Players (2015-2020)
Table 23. Global Top Nanomedicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanomedicine as of 2019)
Table 24. Global Nanomedicine by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Nanomedicine Product Solution and Service
Table 27. Date of Enter into Nanomedicine Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Nanomedicine Market Size by Type (2015-2020) (Million US$)
Table 30. Global Nanomedicine Market Size Share by Type (2015-2020)
Table 31. Global Nanomedicine Revenue Market Share by Type (2021-2026)
Table 32. Global Nanomedicine Market Size Share by Application (2015-2020)
Table 33. Global Nanomedicine Market Size by Application (2015-2020) (Million US$)
Table 34. Global Nanomedicine Market Size Share by Application (2021-2026)
Table 35. North America Key Players Nanomedicine Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Nanomedicine Market Share (2019-2020)
Table 37. North America Nanomedicine Market Size by Type (2015-2020) (Million US$)
Table 38. North America Nanomedicine Market Share by Type (2015-2020)
Table 39. North America Nanomedicine Market Size by Application (2015-2020) (Million US$)
Table 40. North America Nanomedicine Market Share by Application (2015-2020)
Table 41. Europe Key Players Nanomedicine Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Nanomedicine Market Share (2019-2020)
Table 43. Europe Nanomedicine Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Nanomedicine Market Share by Type (2015-2020)
Table 45. Europe Nanomedicine Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Nanomedicine Market Share by Application (2015-2020)
Table 47. China Key Players Nanomedicine Revenue (2019-2020) (Million US$)
Table 48. China Key Players Nanomedicine Market Share (2019-2020)
Table 49. China Nanomedicine Market Size by Type (2015-2020) (Million US$)
Table 50. China Nanomedicine Market Share by Type (2015-2020)
Table 51. China Nanomedicine Market Size by Application (2015-2020) (Million US$)
Table 52. China Nanomedicine Market Share by Application (2015-2020)
Table 53. Japan Key Players Nanomedicine Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Nanomedicine Market Share (2019-2020)
Table 55. Japan Nanomedicine Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Nanomedicine Market Share by Type (2015-2020)
Table 57. Japan Nanomedicine Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Nanomedicine Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Nanomedicine Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Nanomedicine Market Share (2019-2020)
Table 61. Southeast Asia Nanomedicine Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Nanomedicine Market Share by Type (2015-2020)
Table 63. Southeast Asia Nanomedicine Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Nanomedicine Market Share by Application (2015-2020)
Table 65. India Key Players Nanomedicine Revenue (2019-2020) (Million US$)
Table 66. India Key Players Nanomedicine Market Share (2019-2020)
Table 67. India Nanomedicine Market Size by Type (2015-2020) (Million US$)
Table 68. India Nanomedicine Market Share by Type (2015-2020)
Table 69. India Nanomedicine Market Size by Application (2015-2020) (Million US$)
Table 70. India Nanomedicine Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Nanomedicine Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Nanomedicine Market Share (2019-2020)
Table 73. Central & South America Nanomedicine Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Nanomedicine Market Share by Type (2015-2020)
Table 75. Central & South America Nanomedicine Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Nanomedicine Market Share by Application (2015-2020)
Table 77. Combimatrix Company Details
Table 78. Combimatrix Business Overview
Table 79. Combimatrix Product
Table 80. Combimatrix Revenue in Nanomedicine Business (2015-2020) (Million US$)
Table 81. Combimatrix Recent Development
Table 82. Ablynx Company Details
Table 83. Ablynx Business Overview
Table 84. Ablynx Product
Table 85. Ablynx Revenue in Nanomedicine Business (2015-2020) (Million US$)
Table 86. Ablynx Recent Development
Table 87. Abraxis Bioscience Company Details
Table 88. Abraxis Bioscience Business Overview
Table 89. Abraxis Bioscience Product
Table 90. Abraxis Bioscience Revenue in Nanomedicine Business (2015-2020) (Million US$)
Table 91. Abraxis Bioscience Recent Development
Table 92. Celgene Company Details
Table 93. Celgene Business Overview
Table 94. Celgene Product
Table 95. Celgene Revenue in Nanomedicine Business (2015-2020) (Million US$)
Table 96. Celgene Recent Development
Table 97. Mallinckrodt Company Details
Table 98. Mallinckrodt Business Overview
Table 99. Mallinckrodt Product
Table 100. Mallinckrodt Revenue in Nanomedicine Business (2015-2020) (Million US$)
Table 101. Mallinckrodt Recent Development
Table 102. Arrowhead Research Company Details
Table 103. Arrowhead Research Business Overview
Table 104. Arrowhead Research Product
Table 105. Arrowhead Research Revenue in Nanomedicine Business (2015-2020) (Million US$)
Table 106. Arrowhead Research Recent Development
Table 107. GE Healthcare Company Details
Table 108. GE Healthcare Business Overview
Table 109. GE Healthcare Product
Table 110. GE Healthcare Revenue in Nanomedicine Business (2015-2020) (Million US$)
Table 111. GE Healthcare Recent Development
Table 112. Merck Business Overview
Table 113. Merck Product
Table 114. Merck Company Details
Table 115. Merck Revenue in Nanomedicine Business (2015-2020) (Million US$)
Table 116. Merck Recent Development
Table 117. Pfizer Company Details
Table 118. Pfizer Business Overview
Table 119. Pfizer Product
Table 120. Pfizer Revenue in Nanomedicine Business (2015-2020) (Million US$)
Table 121. Pfizer Recent Development
Table 122. Nanosphere Company Details
Table 123. Nanosphere Business Overview
Table 124. Nanosphere Product
Table 125. Nanosphere Revenue in Nanomedicine Business (2015-2020) (Million US$)
Table 126. Nanosphere Recent Development
Table 127. Epeius Biotechnologies Company Details
Table 128. Epeius Biotechnologies Business Overview
Table 129. Epeius Biotechnologies Product
Table 130. Epeius Biotechnologies Revenue in Nanomedicine Business (2015-2020) (Million US$)
Table 131. Epeius Biotechnologies Recent Development
Table 132. Cytimmune Sciences Company Details
Table 133. Cytimmune Sciences Business Overview
Table 134. Cytimmune Sciences Product
Table 135. Cytimmune Sciences Revenue in Nanomedicine Business (2015-2020) (Million US$)
Table 136. Cytimmune Sciences Recent Development
Table 137. Nanospectra Biosciences Company Details
Table 138. Nanospectra Biosciences Business Overview
Table 139. Nanospectra Biosciences Product
Table 140. Nanospectra Biosciences Revenue in Nanomedicine Business (2015-2020) (Million US$)
Table 141. Nanospectra Biosciences Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanomedicine Market Share by Type: 2020 VS 2026
Figure 2. Quantum dots Features
Figure 3. Nanoparticles Features
Figure 4. Nanoshells Features
Figure 5. Nanotubes Features
Figure 6. Nanodevices Features
Figure 7. Global Nanomedicine Market Share by Application: 2020 VS 2026
Figure 8. oncology Case Studies
Figure 9. Infectious diseases Case Studies
Figure 10. Cardiology Case Studies
Figure 11. Orthopedics Case Studies
Figure 12. Others Case Studies
Figure 13. Nanomedicine Report Years Considered
Figure 14. Global Nanomedicine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Nanomedicine Market Share by Regions: 2020 VS 2026
Figure 16. Global Nanomedicine Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Nanomedicine Market Share by Players in 2019
Figure 19. Global Top Nanomedicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanomedicine as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Nanomedicine Revenue in 2019
Figure 21. North America Nanomedicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Nanomedicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Nanomedicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Nanomedicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Nanomedicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Nanomedicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Nanomedicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
医療用ナノテクノロジー（ナノメディシン）の世界市場（～2026年） It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular lev…- カドミウムベース量子ドットの世界市場（～2026年） Market Analysis and Insights: Global Cadmium-Based Quantum Dots Market The global Cadmium-Based Quantum Dots market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cadmium-Based Quantum Dots Scope and Market Size Cadmium-Base…
- POC感染性疾患の世界市場（～2026年） POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care. Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies, which has helped the market to grow during the previous forecasted peri…
- 磁気共鳴画像法（MRI）用造影剤の世界市場（～2026年） Market Analysis and Insights: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market The global Contrast Agents for Magnetic Resonance Imaging (MRI) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Contrast …
- 感染症の世界市場（～2026年） When infection attacks the body, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic; including antitubercular), antiviral, antifungal and antiparasitic (including antip…